Bonita Springs, Cape Coral, Melbourne and Orlando locations increase Columbia Care’s Florida dispensary footprint to seven 13 additional locations expected to open in the state by year end pending regulatory approval Flower sales to begin in all locations on December 2nd NEW YORK--(BUSINESS WIRE)--

Third quarter 2019 revenue of $22.1 million, an increase of 123% over prior year period Continued organic growth in key markets with 26 dispensaries now operational across 12 jurisdictions, including recent openings in Delaware, Florida and Maryland The Company has entered into its first M&A

Combination will bring together best-in-class medical, health & wellness and legalized adult use capabilities and product portfolios Columbia Care to become the leading operator in the $1.6B Colorado cannabis market – with proforma trailing-twelve month revenue of $138M, the combination will expand

NEW YORK--(BUSINESS WIRE)-- Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest fully integrated operators in the global medical cannabis industry with licenses across the US and EU, today announced that it will host a conference call on

NEW YORK--(BUSINESS WIRE)-- Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) Co-Founder and Chief Executive Officer Nicholas Vita provided the following statement today congratulating Ohio-based cannabis operator, CannAscend, on the opening of its four

NEW YORK--(BUSINESS WIRE)-- Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest fully integrated operators in the global medical cannabis industry with licenses across the US and EU, today announced that the Company founders, the entire

NEW YORK--(BUSINESS WIRE)-- Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest fully integrated operators in the global medical cannabis industry with licenses across the US and EU, today announced the addition of four new dispensaries

NEW YORK--(BUSINESS WIRE)-- Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest fully integrated operators in the global medical cannabis industry with licenses across the US and EU, today announced its conference schedule for the

Columbia Care partners with FDA approved, GMP certified German developer and manufacturer of ultra-high quality herbal extracts, organic plant-based combination supplements and functional beverages with 75-year history of serving the pharmaceutical and food industries through its well established

BeneCeed poised to become the first formulated botanical cannabinoid investigational medicinal product imported from the US approved by the MHRA Collaboration represents first step in Columbia Care’s efforts to conduct global clinical trials with its proprietary cannabis-based medicines NEW